• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于引导优化的双层单目标算法,用于降低虚拟筛选中的计算成本。

A two-layer mono-objective algorithm based on guided optimization to reduce the computational cost in virtual screening.

机构信息

Supercomputing-Algorithms Research Group (SAL), Agrifood Campus of International Excellence, University of Almería, Carretera Sacramento s/n, La Cañada de San Urbano, 04120, Almería, Spain.

Structural Bioinformatics and High Performance Computing Research Group (BIO-HPC), HiTech Innovation Hub, Universidad Católica San Antonio De Murcia (UCAM), Campus de los Jerónimos, 30107, Murcia, Spain.

出版信息

Sci Rep. 2022 Jul 27;12(1):12769. doi: 10.1038/s41598-022-16913-w.

DOI:10.1038/s41598-022-16913-w
PMID:35896716
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9326156/
Abstract

Virtual screening methods focus on searching molecules with similar properties to a given compound. Molecule databases are made up of large numbers of compounds and are constantly increasing. Therefore, fast and efficient methodologies and tools have to be designed to explore them quickly. In this context, ligand-based virtual screening methods are a well-known and helpful tool. These methods focus on searching for the most similar molecules in a database to a reference one. In this work, we propose a new tool called 2L-GO-Pharm, which requires less computational effort than OptiPharm, an efficient and robust piece of software recently proposed in the literature. The new-implemented tool maintains or improves the quality of the solutions found by OptiPharm, and achieves it by considerably reducing the number of evaluations needed. Some of the strengths that help 2L-GO-Pharm enhance searchability are the reduction of the search space dimension and the introduction of some circular limits for the angular variables. Furthermore, to ensure a trade-off between exploration and exploitation of the search space, it implements a two-layer strategy and a guided search procedure combined with a convergence test on the rotation axis. The performance of 2L-GO-Pharm has been tested by considering two different descriptors, i.e. shape similarity and electrostatic potential. The results show that it saves up to 87.5 million evaluations per query molecule.

摘要

虚拟筛选方法侧重于搜索具有与给定化合物相似性质的分子。分子数据库由大量化合物组成,并且还在不断增加。因此,必须设计快速有效的方法和工具来快速探索它们。在这种情况下,基于配体的虚拟筛选方法是一种众所周知且很有帮助的工具。这些方法侧重于在数据库中搜索与参考化合物最相似的分子。在这项工作中,我们提出了一种名为 2L-GO-Pharm 的新工具,与最近文献中提出的高效稳健软件 OptiPharm 相比,它需要的计算工作量更少。新实现的工具保持或提高了 OptiPharm 找到的解决方案的质量,通过大大减少所需的评估数量来实现这一点。有助于 2L-GO-Pharm 提高可搜索性的一些优势包括降低搜索空间维度和为角度变量引入一些圆形限制。此外,为了在搜索空间的探索和利用之间取得平衡,它实现了两层策略和引导搜索过程,以及对旋转轴的收敛测试。通过考虑两种不同的描述符,即形状相似性和静电势,对 2L-GO-Pharm 的性能进行了测试。结果表明,它为每个查询分子节省了多达 8750 万次评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc6/9329480/cf3b14f05f5f/41598_2022_16913_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc6/9329480/3868349f8237/41598_2022_16913_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc6/9329480/c3ea33121a8e/41598_2022_16913_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc6/9329480/b6d20c1f6740/41598_2022_16913_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc6/9329480/305293869198/41598_2022_16913_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc6/9329480/7f511f204cea/41598_2022_16913_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc6/9329480/d13365ab5bc0/41598_2022_16913_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc6/9329480/f34e7df8adc5/41598_2022_16913_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc6/9329480/6852d3ec6133/41598_2022_16913_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc6/9329480/cf3b14f05f5f/41598_2022_16913_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc6/9329480/3868349f8237/41598_2022_16913_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc6/9329480/c3ea33121a8e/41598_2022_16913_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc6/9329480/b6d20c1f6740/41598_2022_16913_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc6/9329480/305293869198/41598_2022_16913_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc6/9329480/7f511f204cea/41598_2022_16913_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc6/9329480/d13365ab5bc0/41598_2022_16913_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc6/9329480/f34e7df8adc5/41598_2022_16913_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc6/9329480/6852d3ec6133/41598_2022_16913_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc6/9329480/cf3b14f05f5f/41598_2022_16913_Fig9_HTML.jpg

相似文献

1
A two-layer mono-objective algorithm based on guided optimization to reduce the computational cost in virtual screening.一种基于引导优化的双层单目标算法,用于降低虚拟筛选中的计算成本。
Sci Rep. 2022 Jul 27;12(1):12769. doi: 10.1038/s41598-022-16913-w.
2
OptiPharm: An evolutionary algorithm to compare shape similarity.OptiPharm:一种用于比较形状相似度的进化算法。
Sci Rep. 2019 Feb 4;9(1):1398. doi: 10.1038/s41598-018-37908-6.
3
Improving drug discovery through parallelism.通过并行性改进药物发现。
J Supercomput. 2023;79(9):9538-9557. doi: 10.1007/s11227-022-05014-0. Epub 2023 Jan 16.
4
mRAISE: an alternative algorithmic approach to ligand-based virtual screening.mRAISE:一种基于配体的虚拟筛选的替代算法方法。
J Comput Aided Mol Des. 2016 Aug;30(8):583-94. doi: 10.1007/s10822-016-9940-1. Epub 2016 Aug 26.
5
FaissMolLib: An efficient and easy deployable tool for ligand-based virtual screening.FaissMolLib:一种高效且易于部署的基于配体的虚拟筛选工具。
Comput Biol Chem. 2024 Jun;110:108057. doi: 10.1016/j.compbiolchem.2024.108057. Epub 2024 Apr 1.
6
LS-align: an atom-level, flexible ligand structural alignment algorithm for high-throughput virtual screening.LS-align:一种适用于高通量虚拟筛选的原子级、灵活的配体结构对齐算法。
Bioinformatics. 2018 Jul 1;34(13):2209-2218. doi: 10.1093/bioinformatics/bty081.
7
SABRE: ligand/structure-based virtual screening approach using consensus molecular-shape pattern recognition.SABRE:基于配体/结构的虚拟筛选方法,使用共识分子形状模式识别。
J Chem Inf Model. 2014 Jan 27;54(1):338-46. doi: 10.1021/ci4005496. Epub 2013 Dec 23.
8
Benchmark on Indexing Algorithms for Accelerating Molecular Similarity Search.用于加速分子相似性搜索的索引算法基准测试。
J Chem Inf Model. 2020 Dec 28;60(12):6167-6184. doi: 10.1021/acs.jcim.0c00393. Epub 2020 Oct 23.
9
gWEGA: GPU-accelerated WEGA for molecular superposition and shape comparison.gWEGA:用于分子叠加和形状比较的GPU加速WEGA
J Comput Chem. 2014 Jun 5;35(15):1122-30. doi: 10.1002/jcc.23603. Epub 2014 Apr 12.
10
TrixX: structure-based molecule indexing for large-scale virtual screening in sublinear time.TrixX:用于亚线性时间大规模虚拟筛选的基于结构的分子索引
J Comput Aided Mol Des. 2007 May;21(5):223-38. doi: 10.1007/s10822-007-9103-5. Epub 2007 Feb 9.

本文引用的文献

1
Identification of novel αβ-tubulin modulators with antiproliferative activity directed to cancer therapy using ligand and structure-based virtual screening.采用配体和基于结构的虚拟筛选技术,针对癌症治疗,发现具有抗增殖活性的新型αβ-微管蛋白调节剂。
Int J Biol Macromol. 2020 Dec 15;165(Pt B):3040-3050. doi: 10.1016/j.ijbiomac.2020.10.136. Epub 2020 Oct 22.
2
Ligand and structure-based virtual screening applied to the SARS-CoV-2 main protease: an repurposing study.基于配体和结构的虚拟筛选应用于 SARS-CoV-2 主蛋白酶:重新利用研究。
Future Med Chem. 2020 Oct;12(20):1815-1828. doi: 10.4155/fmc-2020-0165. Epub 2020 Aug 13.
3
Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds.
通过对 6 亿种化合物的虚拟筛选鉴定出新型冠状病毒蛋白酶的潜在抑制剂。
Int J Mol Sci. 2020 May 21;21(10):3626. doi: 10.3390/ijms21103626.
4
Scope of 3D Shape-Based Approaches in Predicting the Macromolecular Targets of Structurally Complex Small Molecules Including Natural Products and Macrocyclic Ligands.基于3D形状的方法在预测包括天然产物和大环配体在内的结构复杂小分子的大分子靶点中的应用范围。
J Chem Inf Model. 2020 Jun 22;60(6):2858-2875. doi: 10.1021/acs.jcim.0c00161. Epub 2020 May 5.
5
Is high performance computing a requirement for novel drug discovery and how will this impact academic efforts?高性能计算是新型药物发现的必要条件吗?这将如何影响学术研究工作?
Expert Opin Drug Discov. 2020 Sep;15(9):981-986. doi: 10.1080/17460441.2020.1758664. Epub 2020 Apr 29.
6
COVID-19: consider cytokine storm syndromes and immunosuppression.2019冠状病毒病:考虑细胞因子风暴综合征和免疫抑制。
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
7
Pharmacophore features for machine learning in pharmaceutical virtual screening.药物虚拟筛选中机器学习的药效团特征。
Mol Divers. 2020 May;24(2):407-412. doi: 10.1007/s11030-019-09961-4. Epub 2019 May 27.
8
OptiPharm: An evolutionary algorithm to compare shape similarity.OptiPharm:一种用于比较形状相似度的进化算法。
Sci Rep. 2019 Feb 4;9(1):1398. doi: 10.1038/s41598-018-37908-6.
9
Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases.深度学习和机器智能在计算机药物发现中的最新应用:方法、工具和数据库。
Brief Bioinform. 2019 Sep 27;20(5):1878-1912. doi: 10.1093/bib/bby061.
10
LS-align: an atom-level, flexible ligand structural alignment algorithm for high-throughput virtual screening.LS-align:一种适用于高通量虚拟筛选的原子级、灵活的配体结构对齐算法。
Bioinformatics. 2018 Jul 1;34(13):2209-2218. doi: 10.1093/bioinformatics/bty081.